About

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the…

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the pharmaceutical, food, and cosmetics sectors, with a focus on EU and Italian regulatory advice. He is a native Italian and Slovenian speaker.

European Commission Publishes “ESRS 2.0” for Public Consultation: Draft Closely Follows EFRAG’s Technical Advice with Additional Simplifications for Companies

May 14, 2026

EU CSDDD/CSRD Omnibus Published in Official Journal: Transposition, Delegated Acts, and Guidelines Are Next

February 26, 2026

ABS Enforcement Expected in Spain: Spain Adopted a National Plan to Enforce Access and Benefit-Sharing Rules

January 26, 2026

The CSRD/CSDDD Omnibus Endgame: Key Points for Companies

November 25, 2025

Spain Proposes Strict Sustainability Requirements for Data Centers

September 3, 2025

New Sustainability Reporting Requirements for Data Centers in the EU

August 19, 2024

New EU Wastewater Treatment Fees on Producers of Pharmaceutical and Cosmetic Products

April 10, 2024

Italian Garante Issues Guidance on the Use of AI in the Context of National Healthcare Services

November 8, 2023

WIPO proposes new Patent Disclosure obligations on Genetic Resources: What impact for companies?

September 13, 2023

About

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the…

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the pharmaceutical, food, and cosmetics sectors, with a focus on EU and Italian regulatory advice. He is a native Italian and Slovenian speaker.

Connect:

Subscribe:

Blogs